Influx HealthtechNSE:INFLUX +2.90%21 OCF Margin % is 3.33% as of Mar. 2026, which is 51% below its 10-year median of 6.78. GuruFocus rates NSE:INFLUX with a GF Score™ of 21/100. The stock has 4 warning signs investors should review. Among 961 Drug Manufacturers companies, Influx Healthtech ranks worse than 67.12% on this metric.
The historical rank and industry rank for Influx Healthtech's OCF Margin % or its related term are showing as below:
NSE:INFLUX'
s OCF Margin % Range Over the Past 10 Years
Min: 2.65 Med: 6.78 Max: 9.09
Current: 2.65
During the past 5 years, the highest OCF Margin % of Influx Healthtech was 9.09%. The lowest was 2.65%. And the median was 6.78%.
NSE:INFLUX's OCF Margin % is ranked worse than 67.12% of 961
companies
in the Drug Manufacturers industry
Industry Median: 9.94
vs NSE:INFLUX: 2.65
Influx Healthtech OCF Margin % Related Terms
Influx Healthtech OCF Margin % Historical Data
* Premium members only.
The historical data trend for Influx Healthtech's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Influx Healthtech's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Influx Healthtech OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Influx Healthtech's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Influx Healthtech's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Influx Healthtech (NSE:INFLUX) has a OCF Margin % of 3.33% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Influx Healthtech and its competitors. This is 51% below median its historical median of 6.78. Over the past decade, Influx Healthtech's OCF Margin % has ranged from 2.65 to 9.09. According to the industry distribution chart, Influx Healthtech ranks #645 out of 961 companies in the Drug Manufacturers industry, placing it in the top 67.1%.
Is Influx Healthtech's OCF Margin % too high?
Influx Healthtech's current OCF Margin % of 3.33% is 51% below median its 10-year median of 6.78. Over the past 10 years, this metric has ranged from a low of 2.65 to a high of 9.09. The Drug Manufacturers industry median OCF Margin % is 9.94. Influx Healthtech's value of 3.33% is 66.5% below this industry median. Based on the distribution chart, Influx Healthtech ranks #645 out of 961 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Influx Healthtech has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Influx Healthtech's OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Influx Healthtech ranks #645 out of 961 companies for OCF Margin %. This places Influx Healthtech in the lower half of its industry. The industry median OCF Margin % is 9.94. Influx Healthtech's value of 3.33% is 66.5% below this benchmark. Historically, Influx Healthtech's own OCF Margin % has ranged from 2.65 to 9.09 over the past decade. While the company's 10-year median is 6.78 vs. the industry median of 9.94, Influx Healthtech has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.94, based on 961 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Influx Healthtech's current OCF Margin % of 3.33% is 66.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Influx Healthtech and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Influx Healthtech's current OCF Margin % is 3.33%, which is 51% below median its own 10-year median of 6.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Influx Healthtech stock overvalued right now?
Influx Healthtech (NSE:INFLUX) has a current OCF Margin % of 3.33%. The current OCF Margin % is 3.33%, which is 51% below median its 10-year median of 6.78 and 66.5% below the Drug Manufacturers industry median of 9.94. Influx Healthtech's overall GF Score™ is 21/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Influx Healthtech (NSE:INFLUX), the current OCF Margin % is 3.33% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Influx Healthtech Ltd is a Mumbai-based, healthcare-focused company specialising in contract manufacturing. The company operates manufacturing facilities located in Thane. Its expertise spans the production of Dietary and Nutritional Supplements, Cosmetics, Ayurvedic/Herbal Products, Veterinary Feed Supplements, Homecare Products, Active Pharmaceutical Ingredients (APIs), and finished dosage forms, including tablets, capsules, and injectables. The company generates the majority of its revenue from sale of products.
21GF Score
Get the complete analysis for NSE:INFLUX
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:INFLUX has been successfully added to your 